These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 38176877)
1. Impact of the COVID-19 pandemic on prescription drug use and costs in British Columbia: a retrospective interrupted time series study. Zeitouny S; McGrail K; Tadrous M; Wong ST; Cheng L; Law M BMJ Open; 2024 Jan; 14(1):e070031. PubMed ID: 38176877 [TBL] [Abstract][Full Text] [Related]
2. Psychotropic Medication Prescribing for Children and Adolescents After the Onset of the COVID-19 Pandemic. Valtuille Z; Acquaviva E; Trebossen V; Ouldali N; Bourmaud A; Sclison S; Gomez A; Revet A; Peyre H; Delorme R; Kaguelidou F JAMA Netw Open; 2024 Apr; 7(4):e247965. PubMed ID: 38652474 [TBL] [Abstract][Full Text] [Related]
3. Trends in Incident Prescriptions for Behavioral Health Medications in the US, 2018-2022. Chai G; Xu J; Goyal S; Woods C; Ho A; Song J; Dal Pan G JAMA Psychiatry; 2024 Apr; 81(4):396-405. PubMed ID: 38198145 [TBL] [Abstract][Full Text] [Related]
4. Comparison of Medication Prescribing Before and After the COVID-19 Pandemic Among Nursing Home Residents in Ontario, Canada. Campitelli MA; Bronskill SE; Maclagan LC; Harris DA; Cotton CA; Tadrous M; Gruneir A; Hogan DB; Maxwell CJ JAMA Netw Open; 2021 Aug; 4(8):e2118441. PubMed ID: 34338794 [TBL] [Abstract][Full Text] [Related]
5. The impact of the early COVID-19 pandemic on healthcare system resource use and costs in two provinces in Canada: An interrupted time series analysis. Zeitouny S; Cheung DC; Bremner KE; Pataky RE; Pequeno P; Matelski J; Peacock S; Del Giudice ME; Lapointe-Shaw L; Tomlinson G; Mendlowitz AB; Mulder C; Tsui TCO; Perlis N; Walker JD; Sander B; Wong WWL; Krahn MD; Kulkarni GS PLoS One; 2023; 18(9):e0290646. PubMed ID: 37682823 [TBL] [Abstract][Full Text] [Related]
6. Impact of the COVID-19 Pandemic on Hepatitis C Treatment Initiation in British Columbia, Canada: An Interrupted Time Series Study. Morrow RL; Binka M; Li J; Irvine M; Bartlett SR; Wong S; Jeong D; Makuza JD; Wong J; Yu A; Krajden M; Janjua NZ Viruses; 2024 Apr; 16(5):. PubMed ID: 38793537 [TBL] [Abstract][Full Text] [Related]
7. Trends in Prescription Chronic Pain Medication Use before and during the First Wave of the COVID-19 Pandemic in Québec, Canada: An Interrupted Time Series Analysis. De Clifford-Faugère G; Nguena Nguefack HL; Choinière M; Pagé MG; Blais L; Guénette L; Dorais M; Lacasse A Int J Environ Res Public Health; 2023 Aug; 20(15):. PubMed ID: 37569033 [TBL] [Abstract][Full Text] [Related]
8. Prescription of anxiolytics, sedatives, hypnotics and antidepressants in outpatient, universal care during the COVID-19 pandemic in Portugal: a nationwide, interrupted time-series approach. Estrela M; Silva TM; Gomes ER; Piñeiro M; Figueiras A; Roque F; Herdeiro MT J Epidemiol Community Health; 2022 Apr; 76(4):335-340. PubMed ID: 34625519 [TBL] [Abstract][Full Text] [Related]
9. Drug utilisation in children and adolescents before and after the start of the COVID-19 pandemic: Interrupted time-series analyses in three European countries. Pedersen E; Tripodi E; Aakjær M; Li H; Cantarutti A; Nyberg F; Andersen M; Lupattelli A; Nordeng H Paediatr Perinat Epidemiol; 2024 Aug; 38(6):450-460. PubMed ID: 38299727 [TBL] [Abstract][Full Text] [Related]
10. Impact of COVID-19 Pandemic on Dispensing of Cardiovascular Drugs in Norway: An Interrupted Time Series Study. Ukah UV; Platt RW; Nordeng HME Am J Prev Med; 2024 Apr; 66(4):672-680. PubMed ID: 37972795 [TBL] [Abstract][Full Text] [Related]
11. Dispensing patterns of mental health medications before and during the COVID-19 pandemic in Alberta, Canada: An interrupted time series analysis. Ying LT; Yarema MC; Bousman CA Int J Psychiatry Med; 2023 Mar; 58(2):172-184. PubMed ID: 35502998 [TBL] [Abstract][Full Text] [Related]
12. Trends in medication use at the onset of and during the COVID-19 pandemic in the Republic of Ireland: An interrupted time series study. Mattsson M; Hong JA; Frazer JS; Frazer GR; Moriarty F Basic Clin Pharmacol Toxicol; 2024 Feb; 134(2):231-240. PubMed ID: 37903499 [TBL] [Abstract][Full Text] [Related]
13. Antimicrobial use in Sweden during the COVID-19 pandemic: prescription fill and inpatient care requisition patterns. Nakitanda AO; Karlsson P; Löfling L; Cesta CE; Odsbu I BMC Infect Dis; 2022 May; 22(1):492. PubMed ID: 35610597 [TBL] [Abstract][Full Text] [Related]
14. Antibiotic dispensing during the COVID-19 pandemic: analysis of Welsh primary care dispensing data. Wasag DR; Cannings-John R; Hughes K; Ahmed H Fam Pract; 2022 May; 39(3):420-425. PubMed ID: 34755180 [TBL] [Abstract][Full Text] [Related]
15. Prescription drug use in pregnancy: a retrospective, population-based study in British Columbia, Canada (2001-2006). Daw JR; Mintzes B; Law MR; Hanley GE; Morgan SG Clin Ther; 2012 Jan; 34(1):239-249.e2. PubMed ID: 22169049 [TBL] [Abstract][Full Text] [Related]
16. The impact of OHIP+ pharmacare on use and costs of public drug plans among children and youth in Ontario: a time-series analysis. Miregwa BN; Holbrook A; Law MR; Lavis JN; Thabane L; Dolovich L; Wilson MG CMAJ Open; 2022; 10(3):E848-E855. PubMed ID: 36167420 [TBL] [Abstract][Full Text] [Related]
17. Prescription Drug Dispensing to US Children During the COVID-19 Pandemic. Chua KP; Volerman A; Conti RM Pediatrics; 2021 Aug; 148(2):. PubMed ID: 34285080 [TBL] [Abstract][Full Text] [Related]
18. Impacts of the COVID-19 pandemic on enrollment in medications for opioid use disorder (MOUD) in Vancouver, Canada: An interrupted time series analysis. Eugenia Socias M; Choi JC; Fairbairn N; Johnson C; Wilson D; Debeck K; Brar R; Hayashi K Int J Drug Policy; 2023 Aug; 118():104075. PubMed ID: 37271070 [TBL] [Abstract][Full Text] [Related]
19. Asthma and COPD medicines prescription-claims: A time-series analysis of England's national prescriptions during the COVID-19 pandemic (Jan 2019 to Oct 2020). Barrett R; Barrett R Expert Rev Respir Med; 2021 Dec; 15(12):1605-1612. PubMed ID: 34555287 [TBL] [Abstract][Full Text] [Related]
20. Additional challenges in reaching hepatitis C elimination goals in Germany due to the COVID-19 pandemic - descriptive analysis of drug prescription data from January 2018 to June 2021. Meyer ED; Dudareva S; Kollan C; Mauss S; Wedemeyer H; Schmidt D; Zimmermann R Front Public Health; 2023; 11():1149694. PubMed ID: 37325322 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]